Determinants of Human Receptor Specificity of Influenza A Virus H2N2 Hemagglutinin
Exclusively Licensed
Invention type: Technology
/
Case number: #14302
The present invention provides, among other things, methods, reagents, and systems for the treatment, detection, analysis, and/or characterization of influenza infections.
Researchers
Rahul Raman
/
Xiaoying Koh
/
Karthik Viswanathan
/
Aarthi Chandrasekaran
/
Ram Sasisekharan
Departments: Department of Biological Engineering, School of Engineering
Technology Areas: Biotechnology: DNA & RNA Editing, Synthetic Biology / Diagnostics: Assays / Drug Discovery and Research Tools: Genomics & Proteomics / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
influenza treatment and/or characterization, human-adapted ha polypeptides; vaccines
United States of America | Granted | 9,745,352 -
influenza treatment and/or characterization, human-adapted ha polypeptides; vaccines
United States of America | Granted | 8,802,110 -
human-adapted ha polypeptides, vaccines, and influenza treatment
Australia | Granted | 2,011,305,371
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.